Patent woes lead to sharp sales losses
Friday, October 26, 2012 - 04:50
in Mathematics & Economics
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs